(Q78859747)

English

Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union

scientific article published on 01 February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Arturo Pereira

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

192-201

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

The risks of transfusion-transmitted infection: direct estimation and mathematical modelling

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Retrospective follow-up of recipients and donors of blood donations reactive for anti-HBc or for single HCV antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Detection of hepatitis B virus DNA in blood units with anti-HBc as the only positive serological marker

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Cost-effectiveness of transfusing virus-inactivated plasma instead of standard plasma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

A model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Acute liver failure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Etiology and outcome for 295 patients with acute liver failure in the United States.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Health and economic consequences of HCV lookback

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

The economic burden of hepatitis B in Germany

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

A comparison of the costs and effects of liver transplantation for acute and for chronic liver failure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Estimated risk of transfusion-transmitted viral infections in Spain

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Evaluating the cost-effectiveness of clinical and public health measures

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00280.X

21 January 2018

Identifiers

10.1046/J.1537-2995.2003.00280.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559015%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78859747&oldid=1782054404"